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Abstract: The discovery and description of bioactive substances from natural sources has 
been a research topic for the last 50 years. In this respect, marine animals have been used 
to extract many new compounds exerting different actions. Reproduction is a complex 
process whose main steps are the production and maturation of gametes, their activation, 
the fertilisation and the beginning of development. In the literature it has been shown that 
many substances extracted from marine organisms may have profound influence on the 
reproductive behaviour, function and reproductive strategies and survival of species. 
However, despite the central importance of reproduction and thus the maintenance of 
species, there are still few studies on how reproductive mechanisms are impacted by 
marine bioactive drugs. At present, studies in either marine and terrestrial animals have 
been particularly important in identifying what specific fine reproductive mechanisms are 
affected by marine-derived substances. In this review we describe the main steps of the 
biology of reproduction and the impact of substances from marine environment and 
organisms on the reproductive processes. 
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1. Introduction 
 
1.1. Biology of Reproduction  
 
Reproduction is the biological process by which new individual organisms are generated. In sexual 
reproduction the new organism is a combination of half of the genetic material of the two parents 
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through the fusion of the two gametes: spermatozoon and oocyte [1]. The gametes are formed during 
specific processes such as oogenesis and spermatogenesis, both characterized by a unique process of 
cell division occurring only in gametes, called meiosis, whose goal is the production of highly 
specialized haploid cells for fertilisation. During gametogenesis the two gametes respectively in the 
ovary and the testis undergo maturation whereas gametes are activated at fertilisation. Oocyte 
maturation is the last phase of oogenesis during which the oocyte acquires the competence to be 
ovulated and fertilised. In the majority of the species, the oocyte arrests at different stages of meiotic 
division, in particular the block occurring in the first meiotic prophase marks the state of immature 
oocyte characterized by a prominent nucleus called germinal vesicle (GV). Meiosis is resumed in 
response to a stimulus that is different among the species and meiosis progression occurs with the 
germinal vesicle breakdown (GVBD). Then it progresses until a second arrest at metaphase I (MI) or II 
(MII) that is removed after successful fertilisation. 
Oocyte maturation is usually defined as the period of progression from the first to the second 
meiotic arrest and involves coordinated nuclear and cytoplasmic modifications [2]. If nuclear 
maturation is underlied by the meiotic process, cytoplasmic maturation is a more obscure process and 
involves both morphological and functional alterations related to: (i) changes in the expression profile 
of cell cycle control proteins responsible for driving the oocyte towards developmental competencies 
[3–7]; (ii) relocation of mitochondria and endoplasmic reticulum [8–10]; (iii) transcriptional 
modifications of mRNA [11]; (iv) modification of the plasma membrane permeability [12–15];   
(v) differentiation of the calcium signalling machinery [16].  
The control of oocyte maturation involves a complex interplay between oocyte and the extra 
cellular membranes and the environment, with the participation of numerous metabolic pathways. The 
resumption of meiotic maturation relies on two different mechanisms that are stimulation by 
chemical/hormonal substances and the removal of an inhibitory signal. The former involves the 
production of a ligand that acts on the oocyte at the GV stage inducing the GVBD.  
Meiosis arrest and resumption are modulated by numerous messengers. Many studies have 
provided evidence of the involvement of cyclic nucleotides in the maintenance of meiotic arrest [17]. 
In particular, high levels of cyclic adenosine mono-phosphate (cAMP), some analogues,   
cAMP-dependent protein kinase (PKA) and related substances such as GPR3, act by preventing 
spontaneous maturation and/or blocking GVBD in vitro or, on the contrary, may release oocyte from 
meiotic arrest [18,19].  
Another important factor responsible for meiotic resumption is the M-phase promoting factor 
(MPF) showed for the first time in amphibian oocytes in the ’70s, by Masui [20]. Although most of the 
work on MPF has been carried out with frog and starfish oocytes, accumulated evidence demonstrates 
that this mechanism exists in other animal models, such as mammals and invertebrates [12,16,21–23]. 
There is a general consensus that calcium ions play a fundamental role in the resumption of meiotic 
maturation [4,16,24,25] in different species. The external calcium is involved in meiotic resumption in 
ascidian oocytes [15]. In mouse, calcium oscillations precede GVBD [26] that is delayed by removing 
of external calcium [27]. 
As showed in mammalian oocytes, meiotic maturation is a complex process that involves extensive 
rearrangement of microtubules and actin filaments [28]. Depending on the species, actin filaments 
control chromatin movement during oocyte development and regulation of organelle positioning; they Mar. Drugs 2009, 7 
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also participate in oocyte cortex formation and in polarity establishment. The actin filaments, 
furthermore, play several roles in cortical granule movement, anchoring and exocytosis, and, together 
with myosin, are also involved in polar body emission [29].  
Sperm maturation is defined as the development of the ability of spermatozoa to fertilise eggs. In 
this process, the sperm undergoes morphological, biochemical, and physiological modifications 
initially in the testis (testicular maturation) and later in the epididymis (epididymal maturation). In the 
former, maturation occurs at molecular levels especially during the last phase of spermatogenesis 
known as spermiogenesis; here, the large round haploid spermatide undergoes a dramatic 
morphological and molecular changes including: replacement of histones with protamines, high 
condensation of chromatin, formation of the acrosome, centrioles migration and tail assemblage. In the 
mean time, sperm acquires a functional competence, e.g., acquisition of flagellar beating providing 
forward propulsion and compactness of nuclear and flagellar structures.  
After that, in mammals, sperm function required for fertilisation seems to be developed in the 
epididymis, whereas in marine animals it takes place at the moment of its spawning in the   
environment [1,30]. In marine organisms, spawning, i.e. the release of sperm and often eggs into the 
environment, is a common mechanism of reproduction [31]. The probability of successful fertilization 
in this mating strategy depends on many factors, including the number and the distribution of spawners 
[32], the timing of gamete release [33], the ways in which released gametes are dispersed [34] and 
finally properties of gametes themselves [35]. 
Fertilisation is a highly specialized process of cell to cell interaction that involves many steps such 
as recognition of complementary receptors on the surface of the two gametes, their binding, and the 
fusion of the two plasma membranes [1,36]. During this complex process each gamete activates its 
partner. First, the spermatozoon responds to signal originating from the oocyte and its investments by 
rapidly changing its behaviour, form and function. Multi-step events of sperm activation involve 
motility, chemotaxis, first binding, acrosome reaction, second binding and fusion [1,30,37]. All these 
steps are mediated by known molecules. In particular, the acrosome reaction is an essential 
requirement to render the sperm plasma membrane highly fusible. The acrosome is an organelle 
located on the tip of the sperm head and due to the contact between ligand and receptors on the two 
gametes membranes undergoes the exocytosis [38]. This process that is calcium-mediated allows the 
spermatozoon to cross the zona pellucida that surrounds the oocyte and to take contact with the oocyte 
plasma membrane, after that fusion of the gametes occurs [29]. Following fusion, the spermatozoon 
triggers the quiescent oocyte into metabolic activation inducing electrical, morphological and 
metabolic modifications.  
Electrical changes of the oocyte plasma membrane are a crucial event of the oocyte activation [40]. 
First indications on the role of ion currents at fertilisation were provided in marine animals in the early 
‘80. In the echinoderm oocytes the occurrence of a depolarizing fertilisation potential was attributed to 
the activation of a transient voltage-dependent inward current [41,42]. Subsequently, it was possible to 
determine that the ion fluxes responsible for fertilisation potential crossed the plasma membrane as a 
ion current named fertilisation current [43]. Biophysical studies characterized the channels responsible 
for the fertilisation current as large non-specific and highly conductive ion channels [43,44] and 
subsequently to mainly mediated by sodium currents [14]. In marine worm eggs, the fertilisation Mar. Drugs 2009, 7 
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potential can be thought of as a sum of a Na
+-dependent "sperm receptor potential" and a 
superimposed Ca
2+-dependent action potential [45]. 
Resting potential changes and fertilisation currents has been recorded in many vertebrate oocytes 
such as amphibians [46], hamster [47], rabbit [48], mouse [49], human [50] and bovine [51]. In 
addition, it has been shown that electrical modifications is a mechanism for preventing polyspermy in 
sea urchin [52], marine worm [53], ascidian [54] and Xenopus [46] oocytes. 
Morphological modifications are mainly due to the triggering of the cortical reaction [9] or to the 
contraction of the oocyte body due to a calcium wave that crosses it from pole to pole [55].  
Finally, numerous metabolic modifications occur such as modulation of phosphoinositide pathway 
[5–59] with inositol trisphosphate (IP3) formation. The latter gives rise to a fundamental event in 
oocyte activation [25] that is the release of intracellular calcium. This calcium signal is responsible for 
the exocytosis of cortical granules, resumption of meiosis and activation of development [60–65]. 
A calcium increase may occur in oocytes as single increase, as in amphibians [66] and sea urchins 
[67] or in the form of repetitive oscillations as in ascidians [68] and mammals [69–73]. 
In many species, fusion between sperm and the oocyte occurs at the tip of microvilli, and the actin 
filaments in the microvilli may participate in sperm-egg binding and fusion. As described above, the 
ion currents play a crucial role in the gamete activation and embryo development, so many fertilisation 
blockers are drugs affecting physiological modifications of cytoskeleton and/or ion currents. 
In conclusion, a correct maturation and reciprocal activation of gametes are a pre-requisite for 
successful fertilisation and although their temporal and spatial sequences are not yet fully clarified, 
they involve numerous molecules in form of ligand-substrate complexes, ion current changes, and 
intracellular messenger pathway mobilization [24,74,75]. 
The basic mechanism of fertilisation has been widely debated, at present there are two main 
hypotheses as to how the spermatozoon triggers the oocyte into activation [24]. The first points on the 
binding of the spermatozoon to an oocyte membrane receptor whose signal is in turn transduced by a 
G-protein mechanism. The contrasting idea suggests that the spermatozoon contains a soluble factor 
that is released into the oocyte cytoplasm following the gamete fusion [76,77]. Both the mechanisms 
have been supported by experimental evidence, however in the last decade accumulating evidence 
indicate that the sperm factor hypothesis is more feasible. Other potential candidates were proposed by 
Parrington [78] to be a 33 KDa molecular mass protein and/or a truncated form of the c-kit tyrosine 
kinase receptor [79]. At present it has been well documented that the phospholipase Czeta is soluble 
factor in mammals. However, many investigators are still working to clarify the molecular nature of 
sperm factor in invetebrates [80,81]. 
Embryo development. Successful fertilisation drives the oocyte into meiosis completion and exit 
and the formation of the zygote. This represents the first diploid cell of a new organism that divides by 
mitosis into a number of smaller cells named blastomeres. This process is the cleavage and is different 
depending on the species. Early cleavages are often synchronous, but when synchronism is lost, the 
blastomeres become arranged in layers or groups that mark their specific differences resulting from an 
unequal distribution of cytoplasmic components and/or from induction from neighboring cells. The 
blastomere nuclei are in fact subjected to a cytoplasmic environment that in turn affects gene activity. 
This triggers the programme of development that gives rise to the cell lines, e.g. the future embryo 
tissue (nerve, muscle, epidermis etc.). Transition from maternal gene products to the new individuals Mar. Drugs 2009, 7 
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gene products takes place at different stages of division depending on the species. The first steps of 
embryogenesis share common characteristics among species (blastulation, gastrulation, neurulation), 
however the late events leading to formation of the new individual is totally different, e.g. the 
formation of swimming larvae and metamorphosis occurring in sea water in marine animals vs embryo 
implantation in mammals occurring in utero.  
Although a large volume of literature deals with developmental biology, this is a very complex 
step-by step process that is difficult to summarize [82,83]. 
 
1.2. Marine Drugs 
 
Before describing the action of marine drugs on reproductive mechanisms it is worth to mentioning 
that most, if not all, marine invertebrates harbour microorganisms that include bacteria, cyanobacteria 
and fungi within their tissues extra- and intracellular space [84,85]. The relationship between marine 
invertebrates and marine microorganisms that may serve as food or that live either permanently or 
temporarily inside of marine macroorganisms are highly complex and far from being well understood 
[85–87]. Microorganisms not only serve as food for filter feeders or (in the case of cyanobacteria and 
chemoautotrophic bacteria) enrich the diet of their hosts by carbon and nitrogen fixation, but may 
perhaps also be involved in the biosynthesis of natural products [88]. So, it is clear that there is often a 
difficulty in clarifying the real producer of a marine compound. 
In this review, we have classified marine natural products in two groups: i) compounds with known 
and tested impact on reproduction processes; ii) compounds with plausible impact on reproductive 
processes, chosen on the basis of their molecular mechanisms or targets. For convenience, we describe 
the origin of the drugs on the basis of the zoological scale order. 
 
1.2.1. Marine Natural Products Affecting Reproduction 
 
A limited number of studies have suggested that some of these compounds may have ecological 
roles as allelochemicals, specifically including compounds that may inhibit competing species. These 
allelochemicals may also play a role in defense against potential predators and grazers, particularly 
aquatic invertebrates and their larvae [89].  
In the endless fight between predator and prey, the latter does not play the role of passive victim. 
Beyond direct defense, characterized by a series of mechanisms to avoid being killed, prey have also 
developed indirect long-term defenses, a sort of preventive war against predators: in fact, by producing 
antiproliferative compounds many organisms are able to regulate the population dynamics of their 
marine predators, in particular, interfering with some crucial processes of their reproductive cycle, 
such as: maturation, fertilisation, and early embryo development. 
Cyanobacteria are Gram-negative bacteria capable of producing a wide range of potent toxins as 
secondary metabolites, i. e. the cyanotoxins, whose action is still rather unknown [90,91]. On the 
contrary, other bacteria produce widely known marine neurotoxins; tetrodotoxin (TTX) is one of 
these; it is a voltage-gated sodium current blocker and a major toxic component contained in pufferfish 
of the Family Tetraodontidae. Animals containing TTX are not limited to certain species of puffer. A 
wide variety of marine and terrestrial animals are now known to have TTX, including, but not limited Mar. Drugs 2009, 7 
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to, pufferfish, salamanders, frogs, horseshoe crabs, xanthid crabs, blue-ringed octopus, and starfish 
[92]. In the pufferfish, TTX is concentrated in the ovary and liver, but other organs including skin, 
intestine, and muscle contain TTX in some species of puffer. The reason for such a wide distribution is 
that TTX is not produced by the puffer fish, but is produced by certain species of bacteria including 
Vibrio sp. and comes to be in the animals through the food chain [93–96]. As demonstrated in the 
ascidian Ciona intestinalis, inhibition of sodium currents at the time of fertilisation current generation 
gave rise to a high percentage of anomalous embryos, in which the spatial orientation at the 8/16-cell 
stage is lost [14].  
The difficulty in identifying the real producer is clear also for another drug, maitotoxin (MTX), 
which is an extremely potent toxin obtained from the marine dinoflagellate Gambierdiscus toxicus and 
involved in ciguatera poisoning. MTX was previously detected in the viscera of maito (a small 
herbivorous fish, Ctenochaetus striatus, called “maito” in Tahiti), but further studies [97,98] found a 
good correlation between dinoflagellates in the gut contents and the toxicity of the viscera. The 
dinoflagellate turned out to represent both a new genus and new species, and it was named 
Gambierdiscus toxicus [99]. This toxin is a powerful activator of changes in the intracellular calcium 
concentration and it induces a potassium release from the oocytes simultaneously with a sodium entry 
into unfertilised eggs, although experimental evidence suggests that MTX has no ionophoretic activity 
per se [100–103]. MTX inhibits sea urchin egg fertilisation in a dose-dependent manner but, maybe, 
ion transport perturbations are probably not the direct cause of fertilisation inhibition which could be 
related to a modification of the plasma membrane of the female gametes by this hydrophilic toxin 
[101]. A different effect has been found in mouse, where the results suggest that putative channels 
activated by MTX may be involved in the calcium influx required for mouse sperm acrosome   
reaction [103]. 
Many marine drugs represent a useful tool for studying cellular processes: one of the most famous 
is okadaic acid (OA): the latter acts as a potent inhibitor of protein phosphatases [104] and has turned 
out to be a valuable tool for the study of phosphorylation based processes of cellular signaling [105]. 
The protein serine/threonine phosphatases are a unique family of enzymes that catalyze the specific 
dephosphorylation of phosphoserine or phosphothreonine residues in many cell types. The potent 
activity of OA is remarkably conserved across phyla: this toxin inhibits phosphatase activity in 
mammals, yeast, and higher plants [106]. OA was initially isolated and characterized from the sponges 
Halichondria okadai and H. melanodocia [107]. However, it was later shown to be produced by 
dinoflagellates of the genera Prorocentrum and Dinophysis [104,108–110] and is now considered to be 
of dietary origin rather than a “true” sponge metabolite in terms of its biosynthetic origin. The function 
of OA in sponges is not well understood. Studies by Wiens et al. [111] have provided evidence for at 
least two putative roles of OA within the sponge Suberites domuncula. At low concentrations, OA 
triggers a MAP kinase p38-regulated defense system against bacteria. At elevated concentrations, OA 
acts as an apoptogen and promotes expression of the proapoptotic caspase gene with a simultaneous 
down-regulation of the expression of the anti-apoptotic Bcl-2 homolog gene. In subsequent studies of 
S. domuncula, Schroder et al. [112] suggested that OA may serve as a defense molecule by inducing 
apoptosis in symbiotic or parasitic annelids. [113]. As protein phosphatase specific inhibitor, OA has 
previously been used to stimulate chromatin condensation and premature germinal vesicle breakdown 
in invertebrate and vertebrate oocytes [114–123]. Mar. Drugs 2009, 7 
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Like TTX, brevetoxins are also voltage-gated sodium channel inhibitors, but these marine toxins 
are produced by the dinoflagellate Karenia brevis. Kimm-Brinson and Ramsdell [124] suggested that 
the larvae of medaka fish (Oryzias latipes), but not the eggs, are susceptible to Karenia brevis. In 
contrast, an earlier study with the sea urchin (Lytechinus variegatus) reported that lysates of K. brevis 
administered to eggs did induce developmental abnormalities [125]. This study found that sperm 
motility, egg fertilisation, and development through the blastula stage were unaffected; however, 
mortality and developmental abnormalities occurred in about 50% in embryos at gastrula stage and 
80% in embryos at pluteus stage. The reason for the difference between the study with the red drum 
eggs and the sea urchin eggs may result from the use of K. brevis cells and lysates. The persistence of 
red tides from the late autumn until early spring has suggested that the spawning of some marine 
species may be subject to the adverse effect of red tide toxins. Steidinger et al. [126] also emphasized 
the need for attention to the effects of red tide outbreaks on migratory species, as many species seek 
estuaries for breeding and nursery grounds. Based on studies with other classes of fat-soluble 
contaminants, somatic stores of toxin in fish are transferred during oogenesis and lead to larval   
toxicity [127]. 
Figure 1. Effect of diatom-derived aldheyde 2-trans-4-trans-decadienal (DD) on 
fertilisation currents recorded in the whole-cell voltage clamp configuration in Ciona 
intestinalis oocytes. a: normal fertilisation current; b: oocytes incubated in acetaldehyde 
and then fertilised showed a normal fertilisation current similar to the control; c: oocytes 
incubated in the diatom aldehyde DD (1.5 μg/mL) and then fertilised showed 50% 
reduction in fertilisation current amplitude; d: oocytes incubated in more concentrated DD 
(2  μg/mL) and then fertilised showed complete inhibition of the fertilisation current. 
Modified from Tosti et al. [142].  
 
 
K. brevis red tides have been associated with mortality events of many aquatic animals including 
finfish, sea turtles, and sea birds during their adult stages [126,128–135]. These animals have been 
known to bioaccumulate substantial body burdens of contaminants at times, and in certain cases 
transfer toxicity to offspring during oogenesis. Given the similarity of developmental processes found 
between higher and lower vertebrates, teratogenic effects of brevetoxins have the potential to occur 
among different phylogenetic classes [124]. Mar. Drugs 2009, 7 
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The last 2 decades have seen much controversy concerning the negative impacts that consumption 
of diatoms may have upon copepods. Despite some contrasting data [136], diatom-derived aldehydes 
have been shown to interfere with reproductive mechanism in copepods [137–139] and polychaetes 
and echinoderms [140,141]. In the ascidian Ciona intestinalis, 2-trans-4-trans-decadienal (DD) and 
2-trans-4-cis-7-cis-decatrienal (DT) inhibit the fertilisation current (Figure 1) which is generated in 
oocyte upon interaction with the spermatozoon. In particular, DD may have a dual effect on 
reproductive processes, influencing primary fertilisation events such as gating of fertilisation channels 
and secondary processes such as actin reorganization which is responsible for the segregation of cell 
lineages. In the same study, DD altered actin filaments and mitocondrial migration after contraction, 
leading to a disturbance in cleavage formation (Figure 2A). However, DD also induced larval 
teratogeny at low concentrations (Figure 2B), possibly due to actin perturbation [142]. 
Figure 2. A: Percentage reduction of first cleavage of Ciona intestinalis oocytes incubated 
10 minutes at different concentrations of DD and then fertilised. B: Percentage of embryos 
that reached the larval stage when exposed to different concentrations of DD. Dark shading 
shows the percentage of abnormal larvae. Light shading shows the percentage of normal 
larvae. Insert: top panel shows a normally developed C. intestinalis larva 24 hours after 
fertilisation. Bottom panel: various degrees of malformations such as stunted and elongated 
tail, lack of sensory organ pigmentation, blockage at the 118-cell stage (gastrula). From 
Tosti et al. [142]. 
 
 
Domoic acid (DA) is produced by red alga Chondria armata and planktonic diatoms of the genus 
Pseudo-nitzschia, [143]. Over the last decade, reproductive failure in California sea lions has been 
increasingly associated with harmful algal blooms, most notably DA produced by Pseudo-nitzschia 
spp. [144–146]. The food web plays the primary role in the transmission of DA from Pseudo-nitzschia 
blooms to the California sea lion [144,147]. Common vectors are pelagic planktivorous fish, which 
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accumulate DA-containing diatoms in their gut exceeding toxin concentrations of one part per 
thousand, exceptionally high levels for a natural toxin [147,148]. Additionally, Pseudo-nitzschia, 
which form long chains of cells, will sink to the ocean floor where the DA effectively infiltrates the 
benthic food web and provides an additional source of vectoring [149]. At the level of the receptor in 
the brain, DA binds to kainate subtypes of ionotropic glutamate receptors to induce excitotoxicity by 
release of glutamate and activation of N-methyl-D-aspartate ionotropic glutamate receptors [150]. DA 
crosses the placenta, readily enters the neonatal brain and is retained in the amniotic fluid [151]. The 
early fetal brain is electrically silent, but expresses levels of ionotropic glutamate receptors that guide 
the migration of neurons to the appropriate brain regions and facilitate in the formation correct 
synapses. DA, which is normally cleared rapidly by renal filtration in adult animals, is more toxic to 
animals in utero because of a longer residence time in the fetal-maternal unit and greater access to the 
fetal brain [143]. 
The effect of DA in invertebrates is also known. As a result of the DA exposure, larval growth of 
king scallop, Pecten maximus, measured in terms of shell length and the appearance of the eye-spot, 
and larval survival were significantly compromised. The negative effect of DA exposure suggests that 
this toxin could possibly influence natural recruitment in P. maximus, and it may be necessary to 
protect hatchery-cultured scallop larvae from DA during toxic Pseudo-nitzschia blooms [152]. 
Embryo development is blocked by several drugs isolated from algae: caulerpenyne does not affect 
the microfilament-dependent processes of fertilisation and cytokinesis and allows the beginning of 
mitosis, but prevents normal DNA replication and results in metaphase-like arrest of sea urchin 
embryos [153]; stypoldione uncouples cytokinesis from mitosis at the lowest effective concentrations 
and, although it can disrupt microtubules at relatively higher concentrations, it inhibits cell division at 
the lowest effective concentrations by a selective action on cytokinesis through a mechanism that does 
not appear to involve disassembly of microtubules [154]. 
Sometimes it happens that the same compound may have several contrasting applications: for 
example, a sulfono glycolipid (S-ACT-1) isolated from Gelidiella acerosa, a Sri Lankan marine red 
alga, has a potent human sperm motility stimulating activity in vitro and has the potential to be 
developed into a sperm stimulant [155], but crude extracts from the same species showed elevated 
post-implantation loss. Since post-coital contraceptive activity of another red alga, Gracilaria 
corticata, was due to enhanced pre-implantation loss, marine red algae could represent a useful source 
to be harvested for potential post-coital contraceptive drugs [156]. 
Williamson et al. [157] compared the effects of chemical cues from host algae on different life 
history stages of the sea urchin Holopneustes purpurascens. In sublittoral habitats, H. purpurascens 
occurred primarily on two algal hosts: red alga (Delisea pulchra) and kelp (Ecklonia radiata). Sea 
urchin larvae rapidly metamorphosed in the presence of D. pulchra, but metamorphosis was delayed or 
absent in the presence of E. radiata. D. pulchra produces a polar chemical inducer of metamorphosis 
not found in E. radiata. In contrast to larval metamorphosis, feeding and performance of juvenile and 
adult sea urchins were considerably worse on D. pulchra than on E. radiata. 
To our knowledge, there are just few marine drugs that affect gamete maturation by interacting with 
the cytoskeleton [158–160]: among them, jasplakinolide, a marine compound from sponges, was 
found to arrest oocytes in vitro maturation acting as a microfilament inhibitor, this also affects 
fertilisation in mice [161,162]; theonellapeptolide Ie, from Petrosa species, induced malformed Mar. Drugs 2009, 7 
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maturation through disturbance of cortical F-actin distribution [158]; also strongylophorines, isolated 
from Strongylophora strongylata, inhibited the maturation of starfish oocytes by affecting actin [160]. 
Other marine toxins, the latrunculins, produced by certain sponges, including genus Latrunculia, 
inhibit the microfilament-mediated processes during fertilisation, cleavage and early development in 
sea urchins and mice [163], even more potent than the cytochalasins [164]. 
However, not all the compounds from the sponge have the same target: for example, (-)-10-epi-
axisonitrile-3, a spirocyclic sesquiterpene isocyanide obtained from the marine sponge Geodia exigua, 
immobilized sperm of sea urchin and starfish and in turn block fertilisation, by inhibiting the 
phosphocreatine shuttle participating in the high-energy phosphate metabolism [165]; 
theonellapeptolide IId, isolated from Theonella swinhoei, prevented fertilisation of sea urchin while 
has no effect on early embryonic development of fertilised eggs [166]; also jaspisin, isolated from the 
extract of a marine sponge, Jaspis  species, has different properties: it is a selective inhibitor of 
exoplasmic membrane fusion in echinoderms, blocking fusion between the sperm acrosomal process 
and the egg plasma membrane, and also embryo hatching [167–169]. Similarly to jaspisin, but 
differently from 10-epi-Axisonitrile-3, there are other inhibitors of echinoderm fertilisation isolated 
from sponge, callyspongins A and B [170] and halenaquinol sulfate [171,172], that are able to 
inhibit sperm-egg fusion without affecting sperm motility [165]. Calyculin-A, originally derived from 
the marine sponge Discodermia calyx, is similar to okadaic acid in its potent inhibition of protein 
phosphatases and thus in its impact on reproduction [173,174]. 
Bacteria, algae and sponges are not the only source of marine products: Agius et al. [175] 
demonstrated that under illumination bonellin,  a compound isolated from Bonellia viridis [176], 
causes depression of oxygen uptake by spermatozoa and developmental arrest of echinoid and Bonellia 
eggs. The effect on the eggs may primarily be due to the crosslinking of membrane proteins and to the 
formation of peroxydase that results in the cytolysis of the unfertilised eggs and in the inhibition of 
cleavage [177]. Bonellin is able to arrest the motility of swimming larvae of C. intestinalis, but, since 
the fibrillar structures appear to be unaltered, also this impact seems a consequence of membrane 
modifications [178].  
Recently, spermicidal activity has been found in sea cucumber Bohadschia vitiensis whole-body 
extracts followed by isolation and characterization of bioactive molecule, bivittoside D, able to induce 
human sperm membrane permeabilization [179]. 
Even some early chordates are supposed to be a promising source for marine drugs affecting 
reproduction processes: methoxyconidiol, extracted from the ascidian Aplidium aff. densum [180], 
inhibits the cleavage of sea urchin Sphaerechinus granularis and Paracentrotus lividus fertilised eggs: 
infact, it disrupts M-phase progression and completely blocks cytokinesis without having any effect on 
DNA replication, most likely by affecting microtubule dynamics [181]. In Table 1, we provide a 
summary of the significant data described above. Mar. Drugs 2009, 7 
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Table 1. Summary of significant data reported in the text. 
Drug Source  Target  -  Impact  References 
Tetrodotoxin   Bacteria including 
Vibrio sp. 
-Voltage-gated sodium channels; 
- Inhibition of fertilisation current in C. intestinalis; 
teratogenic effect 
[14,96,200] 
 
Maitotoxin Dinoflagellate 
Gambierdiscus toxicus 
- Cationic channel  
- Mouse acrosome reaction; inhibition of sea urchin egg 
fertilisation 
[101,103] 
Okadaic acid  Dinoflagellates 
Prorocentrum lima and 
Dinophysis spp. 
- Protein phosphatases; 
- Inhibition of phosphorylation based processes of cellular 
signaling 
[104,123] 
Brevetoxin Dinoflagellate  Karenia 
brevis 
-Voltage-gated sodium channels; 
- Teratogenic effect 
[124] 
2-trans,4-trans 
Decadienal 
Diatoms  - Fertilisation current; 
- Inhibition of embryonic development and fertilisation in 
broadcast spawning marine invertebrates 
[140,142] 
Domoic acid  Alga Chondria armata 
Diatom Pseudo-
nitzschia 
- Ionotropic glutamate receptors; 
- Neurotoxicity; reduction of larval growth and survival in 
P. maximus ; reproductive failure in California sea 
lions.  
[143,152] 
Caulerpenyne Alga Caulerpa taxifolia  - Microtubules; 
- Inhibition of first cell division 
[153] 
Stypoldione Alga  Stypopodium 
zonale 
- Sulfhydryl groups of proteins 
- Inhibition of cytokinesis in sea urchin embryos 
[154] 
Sulfonoglycolipid 
S-ACT-1 
Alga Gelidiella acerosa  - Sperm  
- Stimulation of sperm motility 
[155] 
Crude extract  Alga Gracilaria 
corticata,  
- Increase of pre-implantation loss in femal rats  [156] 
Crude extract  Alga Gelidiella acerosa  - Increase of post-implantation loss in female rats  [156] 
Jasplakinolide Sponge Jaspis 
johnstoni 
- Actin; 
- Arrest of in vitro maturation 
[161,162] 
Theonellapeptolide 
Ie  
Sponge Petrosia   - Cortical F-actin distribution;  
- Abnormal maturation  
[158] 
Strongylophorine Sponge Strongylophora 
strongylata 
-Actin;  
-Inhibition of the maturation of starfish oocytes 
[160] 
Latrunculin Sponge  Latrunculia 
magnifica 
- Microfilament;  
- Inhibition of microfilament-mediated processes during 
fertilisation, cleavage and early development in sea 
urchins and mice. 
[163] 
(-)-10-epi-Axiso-
nitrile-3 
Sponge Geodia Exigua  - Phosphocreatine shuttle;  
- Sea urchin and starfish sperm immobilization 
[165] 
Theonellapeptolide 
IId  
Sponge Theonella 
swinhoei 
- Inhibition of fertilisation of the sea urchin  [166] 
Jaspisin Sponge  Jaspis sp.  - Exoplasmic membrane fusion; 
- Block fusion between sperm acrosomal process and egg 
plasma membrane; block of embryo hatching 
[167–169] Mar. Drugs 2009, 7 
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Table 1. Cont. 
Callyspongins A 
and B 
Sponge Callyspongia 
truncata 
- Inhibition of sperm-egg fusion  [170] 
Halenaquinol 
sulfate 
Sponge Xestospongia 
sapra 
- Inhibition of sperm-egg fusion  [171,172] 
Calyculin A  Sponge Discodermia 
calyx 
- Protein phosphatases 
- Modulation of phosphorylation based processes of 
cellular signalling 
[174] 
Bonellin Echiura Bonellia viridis  - Membrane proteins;  
- Formation of peroxydase; cytolysis of unfertilised eggs, 
inhibition of cleavage and of larval motility  
[178] 
Bivittoside D  Sea cucumber 
Bohadschia vitiensis 
- Sperm; 
- Membrane permeabilization; spermicide activity in 
human 
[179] 
Methoxyconidiol Ascidian  Aplidium aff. 
densum 
- Microtubules; 
- Inhibition of cleavage 
[180,181] 
 
1.2.2. Potential Impact of Marine Drugs  
 
As described above, reproduction is a complex process characterized by many crucial steps. It is 
clear that every marine compound able to affect in some way one of these events could affect 
reproduction either in natural setting and in vitro. A good example to better understand the huge 
potential of marine organisms as drug source is given by marine sponges. The latter have been 
considered to be a gold mine during the past 50 years, with respect to the diversity of their secondary 
metabolites [182]. A huge amount of marine products has been described [183–187] and sponges, in 
particular, are the source of more than 5,300 different products. Every year hundreds of new 
compounds are being discovered [184–186], leading to identification of novel therapeutic agents 
showing a broad spectrum of pharmacological activity; therefore, more marine natural products will 
probably become potential leads for clinical development as novel therapeutic agents for the treatment 
of multiple disease categories [188–190]. 
Marine compounds showed different effects on many molecules that are in different ways involved 
in reproduction, for example, they inhibit protein kinase C [113,191–193], calcium [194–196], sodium 
[197–201] and potassium channels [202–206]. Similarly, other targets are IP3 receptors, endoplasmic 
reticulum calcium pumps [207], microtubules [208–216]; microfilaments [217–221]; and plasma 
membrane [222,223].  
Even though this is not proved yet, we may hypothesize their plausible impact on reproduction on 
the basis of their molecular targets, either in vivo and in vitro. Over the last few decades significant 
efforts have been made, by both pharmaceutical companies and academic institutions, to isolate and 
identify new marine-derived natural products. Because of the diversity in ocean life many new 
potentially interesting compounds are continuously being discovered. 
Despite the risks associated with marine toxins, such as food poisoning or harmful algal blooms, 
these biogenic compounds have proven their advantage and potential in several fields, particularly as 
new therapeutic agents for a variety of diseases: in fact, marine ecosystem is an enormously rich Mar. Drugs 2009, 7 
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source of natural products with promising therapeutic usefulness in oncology, providing anticancer 
agents with novel mechanisms of action [224–227].  
This review reports current understanding of the impacts of compounds from marine organisms on 
the main reproductive processes and some of their specific mechanisms underlying gametogenesis, 
fertilisation and very early embryo development. Although most of the data provide evidence that such 
compounds adversely affect reproductive success, marine drugs may represent a wide source with 
potential application in improving reproductive fitness.  
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